NLRP3 and type 2 diabetes mellitus: Spironolactone treatment reduced the number of active caspase-1-positive-macrophages in the db/db mice (Figure 2d), supporting the theory that aldosterone activates the NLRP3 inflammasome in the immune cells of mice with type 2 diabetes.